Spain: "Radiotherapy dosing is key" in cancer strategy:
This article was originally published in Clinica
A carefully tailored combination of radiotherapy and chemotherapy is the best strategy for treating cancer. So agreed experts across the two fields, at the end of the first International Chemo/Radiotherapy Symposium, held in Elche (Alicante) last month. The event was hosted by Spain's medical oncology (SEOM), radiotherapeutic oncology (AERO) and cancer research (ASEICA) societies, with a view to developing optimal cancer care strategies. Careful dosification and monitoring is crucial to achieving the successes that combination therapies have demonstrated in improving cure rates and minimising damage to organ function and tissue, said AERO president Dr Manuel de las Heras.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.